Doroin, Michelle .
HRN: 00-71-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2025
MUPIROCIN 2%, 15G (TUBE)
03/25/2025
04/01/2025
TOPICAL
Apply On Surgical Site
BID
SP TAHBSO
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes